关于GnRH类似物对心血管的影响的性别差异
Matthew W S Lim1, Angela K Lucas-Herald1,2, Avril Mason2
1School of Cardiovascular & Metabolic Health, University of Glasgow, Glasgow, UK.
The Journal of endocrinology
|January 24, 2024
概括
用于各种疾病的淋巴激素释放激素 (GnRH) 类似物可能会增加心血管风险. 本综述讨论了男性和女性的这些风险,考虑了性别和年龄等因素.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 下垂体-垂体-腺轴对于生殖和治疗目标至关重要.
- 激素释放激素 (GnRH) 的类似物抑制性类固醇合成,用于癌症,不孕症和性别障碍症.
- 人们担心GnRH类似物对心血管的副作用.
研究的目的:
- 在不同人群中审查GnRH类似物对心血管的影响.
- 调查这些心血管影响的潜在基于性别的差异.
- 探索性激素受体在血管系统和混因素中的作用.
主要方法:
- 现有文献的叙述性审查.
- 对男性和女性使用GnRH模拟物的数据分析.
- 讨论诸如恶性瘤,年龄和不孕不育等混杂因素.
主要成果:
- GnRH类似物与男性主要的不良心血管事件有关,特别是那些患有前列腺癌的人.
- 接受GnRH类似物治疗乳腺癌的女性可能面临高血压的风险增加.
- 该审查考虑了不同年龄组和性别的影响.
结论:
- 由于GnRH类型的广泛使用,GnRH类型的心血管作用需要仔细考虑.
- 性似乎在这些类似物对心血管的影响中起作用.
- 需要进一步的研究才能充分理解和减轻这些风险.
更多相关视频
相关概念视频
Antianginal Drugs: Nitrates and β-Blockers
592
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
592
Adrenergic Antagonists: ɑ and β-Receptor Blockers
448
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
448
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
803
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
803
Antihypertensive Drugs: Vasodilators
525
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
525
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K


